Literature DB >> 23291659

Neoadjuvant versus adjuvant systemic therapy for operable breast cancer: equivalent outcomes?

Barbara L Smith.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23291659     DOI: 10.1097/SLA.0b013e318280a688

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  5 in total

1.  Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement.

Authors:  Ramon Colomer; Cristina Saura; Pedro Sánchez-Rovira; Tomás Pascual; Isabel T Rubio; Octavio Burgués; Lourdes Marcos; César A Rodríguez; Miguel Martín; Ana Lluch
Journal:  Oncologist       Date:  2019-02-01

2.  Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction.

Authors:  Nicholas B Abt; José M Flores; Pablo A Baltodano; Karim A Sarhane; Francis M Abreu; Carisa M Cooney; Michele A Manahan; Vered Stearns; Martin A Makary; Gedge D Rosson
Journal:  JAMA Surg       Date:  2014-10       Impact factor: 14.766

3.  Development and Validation of a Nomogram to Predict the Probability of Breast Cancer Pathologic Complete Response after Neoadjuvant Chemotherapy: A Retrospective Cohort Study.

Authors:  Yijun Li; Jian Zhang; Bin Wang; Huimin Zhang; Jianjun He; Ke Wang
Journal:  Front Surg       Date:  2022-06-09

4.  A nomogram based on clinicopathological features and serological indicators predicting breast pathologic complete response of neoadjuvant chemotherapy in breast cancer.

Authors:  Yijun Li; Jian Zhang; Bin Wang; Huimin Zhang; Jianjun He; Ke Wang
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

5.  Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors.

Authors:  I P C Buzatto; A Ribeiro-Silva; J M Andrade; H H A Carrara; W A Silveira; D G Tiezzi
Journal:  Braz J Med Biol Res       Date:  2017-01-26       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.